Magnesium sulfate 1 gram (IV or IM injection) Stress and nerve support, calming, improves insomnia
Acronyms A1C - Hemoglobin A1C ADA - American Diabetes Association CVD - Cardiovascular disease DM - Diabetes mellitus FBS - Fasting blood sugar GFR - Glomerular filtration rate GI - Gastrointestinal GLP-1 - Glucagon-like peptide-1 OSA - Obstructive sleep apnea RCT - Randomized controlled trial T2DM - Type 2 diabetes mellitus Thyroid C-cell tumor = Thyroid medullary tumor DRUGS IN CLASS Dual GLP-1 and GIP agonists Tirzepatide (Mounjaro) - marketed for diabetes Tirzepatide (Zepbound) - marketed for weight loss MECHANISM OF ACTION GLP-1 and GIP GLP-1 stands for "glucagon-like peptide-1," and GIP stands for "glucose-dependent insulinotropic polypeptide." GIP is also sometimes referred to as "gastric inhibitory polypeptide." GLP-1 and GIP are hormones secreted by specialized cells in the small intestine in response to food consumption
Its become increasingly apparent that GLP-1 treatment may have a negative impact on alcohol consumption
The inability to definitively establish causality is a constraint shared by all pharmacovigilance studies and observational cohort studies [Reference Ruiz, Cocores, Tosti, Goadsby and Monteith50, Reference Wichelmann, Abdulmujeeb and Ehrenpreis51]
Vadhan-Raj S, Broxmeyer HE, Andreeff M , Bandres JC, Buescher ES, Benjamin RS, Papadopoulos NE, Burgess A, Patel S, Plager C, Hittelman WN, McAlister I, Garrison L, Williams DE
Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation
